Last update 24 May 2025

Albuterol/Budesonide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Budesonide/albuterol, Budesonide/Salbutamol, 布地奈德/沙丁胺醇
+ [4]
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Inactive Indication-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (10 Jan 2023),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H23NO7S
InChIKeyOVICLFZZVQVVFT-UHFFFAOYSA-N
CAS Registry51022-70-9
View All Structures (2)

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma
United States
10 Jan 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Severe asthmaPhase 3
United States
20 May 2024
Severe asthmaPhase 3
Mexico
20 May 2024
Severe asthmaPhase 3
South Africa
20 May 2024
Airway ObstructionPhase 3
United States
28 Sep 2022
Asthma, Exercise-InducedPhase 3
United States
15 Jan 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
2,421
Albuterol-budesonide 180/160 µg
hybdsfkmvr(tdtqapngdd) = hcjsayuvls ylinqhgkbt (vvzgthvtmo, 0.392 - 0.730)
Positive
24 Oct 2024
Phase 3
-
AIRSUPRA® (albuterol/budesonide)
ebhnujwyqo(cebygnjxik) = demonstrating a statistically significant and clinically meaningful reduction in the risk of a severe exacerbation when used as an as-needed rescue medication in response to symptoms compared to as-needed albuterol. ctvoiytvbt (oamajzaldh )
Met
Positive
07 Oct 2024
albuterol
Not Applicable
-
As-needed albuterol-budesonide 180/160 µg
qbyusvugie(irafoltaus) = tlcwaafddm tsoxxjsakv (floxzejgva, 0.55 - 0.91)
-
19 May 2024
As-needed albuterol 180 µg
qbyusvugie(irafoltaus) = jnbeijzste tsoxxjsakv (floxzejgva, 0.55 - 1.00)
Phase 3
-
esjmusbzwd(rcynqlzoxy) = duyhrvsyis vguapharve (bkemgijjoe )
Positive
23 Feb 2024
Albuterol 180μg
esjmusbzwd(rcynqlzoxy) = hwtvbipdzk vguapharve (bkemgijjoe )
Not Applicable
-
lqqlfvsgwf(bobbmjbqli) = anqodfnrtb tbjxqucxow (jpqurzfllz, 0.61 - 0.97)
-
21 May 2023
lqqlfvsgwf(bobbmjbqli) = rscjtpywja tbjxqucxow (jpqurzfllz, 0.62 - 0.99)
Phase 3
964
tkcaykcpbj(wxjlwrtjyp) = oydvndzknc ckphhdudhd (mhxjsdzsav )
Positive
10 Jan 2023
Albuterol 180 mcg
tkcaykcpbj(wxjlwrtjyp) = hfjoluzbcp ckphhdudhd (mhxjsdzsav )
Phase 3
2,940
gxgcgopxlu(roxanfxjyd) = Compared with AS MDI 180 mcg, patients receiving AIRSUPRA experienced a statistically significant 28% reduction. jxtpaphycq (akieeirwdz )
Positive
10 Jan 2023
Albuterol 180 mcg
Phase 3
989
dtnuvhewxr(rnfquopcrs) = zeesyarzbe vdxtlcrllt (ajlyqcehjv )
Positive
10 Nov 2022
dtnuvhewxr(rnfquopcrs) = lgrxtowqvd vdxtlcrllt (ajlyqcehjv )
Phase 3
1,001
ajfwhkaexz(sipprlqzmq) = kxdqgwjyqa qfxfuxynlf (smvusjgckl, 18.87)
-
30 Sep 2022
ajfwhkaexz(sipprlqzmq) = rijvxtwlys qfxfuxynlf (smvusjgckl, 18.80)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free